SingHealth Investigational Medicine Unit (IMU) is a dedicated early phase clinical research unit, which supports the research of commercial partners and independent investigators. Its projects are supported by a team of dedicated staff comprising clinical research coordinators, clinical research nurses, trained in Good Clinical Practice (ICH-GCP). Located within Singapore General Hospital, SingHealth IMU specialises in diseases that impact patients in Asia, including oncology, haematology, cardiology, gastroenterology, infectious disease and endocrinology.
6323 7532 / 6323 7544 [email protected]
Tailored Medical SpecialitiesSingHealth IMU offers tailored services to its research partners, including: • Specimen collection, handling and processing• Coordination with external central laboratories • Project management of trials • Preparation for external audit and inspection• Conduct of trials adhering to ICH-GCP and SingHealth Centralised Institutional Review Board (CIRB) guidelines
Ready access to a wide range of research services
Here in SingHealth IMU, we have established links with other research services under the SingHealth Group, including but not limited to:
• PET, CT and MRI facilities
• Nuclear medicine services
• Animal research facilities for pre-clinical work
• Biobanking services
• Investigational and chemotherapy pharmacy services
• A kitchen service, which can provide metabolic diets for feed-controlled studies
• CAP-certified pathology laboratories
